Mondira Chowdhury

Mondira Chowdhury is a seasoned professional with extensive experience in the pharmaceutical industry, currently serving as Global Commercial Lead for Rare Disease at Ipsen since August 2021. In this role, Mondira has successfully led global launch strategies and market expansion plans for rare disease assets, demonstrating expertise in cross-functional leadership and stakeholder alignment. Prior positions at Ipsen include roles in oncology sales, business insights, and reimbursement strategy, showcasing a strong foundation in market access and analytics. Previously, at Teva Pharmaceuticals, Mondira managed product launches and marketing initiatives, further honing skills in project management and customer engagement. Mondira holds an MBA from Ivey Business School at Western University and a BBA from the University of Toronto Scarborough.